Project Details
Description
Clinical Study Agreement for Protocol Number A4091031, A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Proof Of Concept Study Of The Analgesic Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy
| Status | Finished |
|---|---|
| Effective start/end date | 1/28/10 → 10/14/11 |
Funding
- PFIZER, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.